Here, we propose a simple method to increase the number of M-CSFR-positive BM-MΦ that utilizes the reducing agent DTT that may be useful in the investigation of the relationship between the downregulation of M-CSFR and some diseases such as atherosclerosis. This evidence concerns the gene CSF1R and atherosclerosis.